J Travel Med 27(3):taaa041 Kumar S, Maurya VK, Prasad AK, Bhatt MLB, Saxena SK (2020) Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV)
Eli Lilly published the results of its ATTAIN-1b trial for obesity in September 2025 7 , which compared orforglipron to placebo in more than 3,100 adults without diabetes, with a BMI of 30+ or 27-30 with an obesity-related complication including hypertension, dyslipidaemia, cardiovascular disease or obstructive sleep apnoea and a history of at least one patient-reported unsuccessful dietary effort to lose body weight, who have tried unsuccessfully to lose weight with diet alone
Three mice completed all the procedures, and no mice died during [ 18 F]FB(ePEG12)12-exendin-4 PET/CT scans
Here's What's Included: --------------------------
doi: 10.1001/jama.2015.9676 31 SendaMOgawaSNakoKOkamuraMSakamotoTItoS
It is just such a powerful tool that dropping it leaves a huge gaping void in their treatment plan that most everyone struggles to fill in with lifestyle changes